In contrast, In the p48-Cre/LSL-KrasG12D/p53Flox/Flox (KPC) genetically engineered mouse models, combined administration of FAK inhibitors with checkpoint immunotherapy and radiation led to complete tumor regression and long-term survival in spontaneous PDA mice. The gene discussed is PTK2; the disease is Patent ductus arteriosus.